Emami Limited Reports Q2 Results, Declares Rs 4 Per Share Interim Dividend
Emami Limited has declared a first interim dividend of Rs 4 per equity share for FY 2025-26, payable by December 9, 2025. The company has made strategic investments by converting loan receivables into equity in Brillare Science Limited and Helios Lifestyle Limited, and into Optionally Convertible Debentures of Cannis Lupus Services India Private Limited. Additional investments were made in Cannis Lupus Services. Emami's Assam facility continues to benefit from tax advantages, resulting in MAT credit recognition of Rs 3,775.00 lacs for the half-year.

*this image is generated using AI for illustrative purposes only.
Emami Limited , a leading Indian personal care and healthcare company, has reported its financial results for the quarter and half-year ended September 30, 2025, along with several key corporate actions.
Interim Dividend Announcement
The Board of Directors has approved a first interim dividend of Rs 4 per equity share (400%) for the financial year 2025-26. The dividend will be payable on or before December 9, 2025, with November 14, 2025 set as the record date. This dividend will be distributed across 43.65 crore equity shares.
Corporate Actions and Investments
During the period, Emami made several strategic financial moves:
- Converted loan receivables into equity investments in two subsidiaries:
- Brillare Science Limited: Rs 2,153.00 lacs
- Helios Lifestyle Limited: Rs 855.00 lacs
- Converted Rs 820.00 lacs of loan receivables into Optionally Convertible Debentures of Cannis Lupus Services India Private Limited
- Made additional investments of Rs 400.00 lacs in Cannis Lupus Services India Private Limited
Tax Benefits
The company's manufacturing facility in Assam continues to benefit from income tax advantages under section 80IE. This resulted in the recognition of MAT (Minimum Alternate Tax) credit of Rs 3,775.00 lacs for the six-month period.
Financial Performance Overview
While detailed financial metrics for the quarter were not provided in the update, the company has reported its unaudited financial results for the quarter and half-year ended September 30, 2025.
Outlook
Emami's strategic investments in its subsidiaries and the conversion of loan receivables into equity and debentures indicate a focus on strengthening its group companies. The dividend payout and tax benefits from its Assam facility may be seen as positive factors for the company's financial stability and shareholder value.
Investors and analysts may look forward to more detailed financial metrics to assess the company's performance in the context of current market conditions and its growth strategies.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.35% | +1.22% | -2.19% | -18.60% | -19.06% | +36.15% |












































